ClinicalTrials.gov record
Completed No phase listed Observational Results available

Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB

ClinicalTrials.gov ID: NCT01166230

Public ClinicalTrials.gov record NCT01166230. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 8:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open, Non-interventional, Retrospective, Comparative, Multicenter Follow-up Study in Patients Included in the Previously Completed Clinical Study PCB305/04, to Assess Longer-term Recurrence Rates in Patients After Hexvix® (Cysview®)Fluorescence Cystoscopy/Transurethral Resection of the Bladder (TURB) or White Light Cystoscopy/TURB

Study identification

NCT ID
NCT01166230
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Photocure
Industry
Enrollment
551 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2010
Primary completion
Nov 30, 2010
Completion
Nov 30, 2010
Last update posted
Apr 8, 2019

2010

United States locations

U.S. sites
14
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Stanford Cancer Center, Department of Urology Stanford California 94305-5820
V.A. Medical Center Gainesville Florida 32608
University of Miami School of Medicine Miami Florida 33136
South Florida Clinical Research Center, Inc. Pembroke Pines Florida 33028
The Emory Clinic, Dept of Urology Atlanta Georgia 30322
Boston University School of Medicine Boston Massachusetts 02118
Urologic Clinical Research Unit, Gonda 7102, Mayo Clinic Rochester Rochester Minnesota 55905
Hackensack University Medical Center Hackensack New Jersey 07601
Mount Sinai Medical Center, Department of Urology New York New York 10029-6574
URMC Rochester New York 14642
Thomas Jefferson Medical College, Department of Neurology Philadelphia Pennsylvania 19107
Vanderbilt University Medical Center, Department of Urologic Surgery Nashville Tennessee 37232-2765
Baylor College of Medicine, Scott Department of Urology Houston Texas 77030-2726
The University of Texas MD Anderson cancer center Houston Texas 77030-4009

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01166230, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2019 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01166230 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →